Halozyme Therap
HALO----
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Preview: Halozyme Therap(HALO) predict that the Revenue is 376.71 M (+42.23%), Beat estimate;the EBIT is 184.52 M (+30.37%), Miss estimate;the EPS is 1.22 (+31.18%), Miss estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
0.38B42.23%
0.36B35.56%
+0.02B6.67%
EBITMiss expectations
0.18B30.37%
0.20B40.25%
-0.01B9.88%
EPSMiss expectations
1.2231.18%
1.272536.83%
-0.05255.65%
Upcoming earnings report - FY2026 Q2 Earning Release
Available dateAug 6, 2026
Estimate Revenue402.28 M
Estimate EBIT244.01 M
Estimate EPS1.4766
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf